Abstract
The evolution of multicellular organisms composed of tissues with distinct morphologies and physiological functions has involved the appearance of novel genes coding for extracellular matrix (ECM) molecules. The ECM consists of four major classes of proteins: collagens, proteoglycans, non-collagenous structural proteins, and glycoproteins. Our knowledge of how these molecules act in concert to assemble intricate networks that provide tissues with their unique design, biomechanical properties, and stability has advanced rapidly over the last three decades. Although the ECM was first perceived to be an inert scaffold, it is now common knowledge that ECM components have dynamic and complex activities that affect all cellular activities. The focus of this chapter is on the tenascin family and Secreted Protein, Acidic, Rich in Cysteine, which are members of the “matricellular” subset of ECM glycoproteins. In contrast to polymer-forming pro-adhesive glycoproteins, such as fibronectin and laminins, these glycoproteins are not integrated into ECM scaffolds but, rather, exist as transient, diffusible, components of interstitial matrices and basement membranes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ballard VL, Sharma A, Duignan I, Holm JM, Chin A, Choi R, Hajjar KA, Wong S-C, Edelberg JM (2006) Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. FASEB J 20(6):717–719
Barker TH, Baneyx G, Cardó-Vila M, Workman GA, Weaver M, Menon PM, Dedhar S, Rempel SA, Arap W, Pasqualini R, Vogel V, Sage EH (2005a) SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 280(43): 36483–36493
Barker TH, Framson P, Puolakkainen PA, Reed M, Funk SE, Sage EH (2005b) Matricellular homologs in the foreign body response: hevin suppresses inflammation, but hevin and SPARC together diminish angiogenesis. Am J Pathol 166(3):923–933
Bassuk JA, Pichler R, Rothmier JD, Pippen J, Gordon K, Meek RL, Bradshaw AD, Lombardi D, Strandjord TP, Reed M, Sage EH, Couser WG, Johnson R (2000) Induction of TGF-[bgr]1 by the matricellular protein SPARC in a rat model of glomerulonephritis. Kidney Int 57(1): 117–128
Basu A, Kligman L, Samulewicz S, Howe C (2001) Impaired wound healing in mice deficient in a matricellular protein SPARC (osteonectin, BM-40). BMC Cell Biol 2(1):15
Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M (1994) PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol 125(4): 917–928
Bhoopathi P, Chetty C, Gujrati M, Dinh DH, Rao JS, Lakka SS (2010) The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine. Br J Cancer 102(3): 530–540
Bjarnegård M, Enge M, Norlin J, Gustafsdottir S, Fredriksson S, Abramsson A, Takemoto M, Gustafsson E, Fässler R, Betsholtz C (2004) Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 131(8): 1847–1857
Blazejewski SLBB, Boussarie L, Blanc JF, Malaval L, Okubo K, Saric J, Bioulac-Sage P, Rosenbaum J (1997) Osteonectin (SPARC) expression in human liver and in cultured human liver myofibroblasts. Am J Pathol 151(3):651–657
Borsi L, Balza E, Castellani P, Carnemolla B, Ponassi M, Querzé G, Zardi L (1994) Cell-cycle dependent alternative splicing of the tenascin primary transcript. Cell Commun Adhes 1(4): 307–317
Borsi L, Balza E, Gaggero B, Allemanni G, Zardi L (1995) The alternative splicing pattern of the tenascin-C pre-mRNA is controlled by the extracellular pH. J Biol Chem 270(11): 6243–6245
Boutet I, Jollivet D, Shillito B, Moraga D, Tanguy A (2009) Molecular identification of differentially regulated genes in the hydrothermal-vent species Bathymodiolus thermophilus and Paralvinella pandorae in response to temperature. BMC Genomics 10(1):222
Bradshaw A (2009) The role of SPARC in extracellular matrix assembly. J Cell Commun Signal 3(3–4):239–246
Bradshaw AD, Reed MJ, Carbon JG, Pinney E, Brekken RA, Sage EH (2001) Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice. Wound Repair Regen 9(6):522–530
Bradshaw AD, Puolakkainen P, Dasgupta J, Davidson JM, Wight TN, Sage EH (2003) SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 120(6):949–955
Brekken RA, Sage EH (2000) SPARC, a matricellular protein: at the crossroads of cell–matrix. Matrix Biol 19(7):569–580
Brellier F, Hostettler K, Hotz H-R, Ozcakir C, Çöloğlu SA, Togbe D, Ryffel B, Roth M, Chiquet-Ehrismann R (2011) Tenascin-C triggers fibrin accumulation by downregulation of tissue plasminogen activator. FEBS Lett 585(6):913–920
Brellier FME, Chiquet M, Ferralli J, van der Heyden M, Orend G, Schittny JC, Chiquet-Ehrismann R, Tucker RP (2012) The adhesion modulating properties of tenascin-W. Int J Biol Sci 8(2): 187–194
Bristow J, Tee M, Gitelman S, Mellon S, Miller W (1993) Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol 122(1):265–278
Busch E, Hohenester E, Timpl R, Paulsson M, Maurer P (2000) Calcium affinity, cooperativity, and domain interactions of extracellular EF-hands present in BM-40. J Biol Chem 275(33): 25508–25515
Cao Y (2009) Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal 2(59):re1
Carey WA, Taylor GD, Dean WB, Bristow JD (2010) Tenascin-C deficiency attenuates TGF-β-mediated fibrosis following murine lung injury. Am J Physiol Lung Cell Mol Physiol 299(6):L785–L793
Chavez-Muñoz C, Hartwell R, Jalili RB, Jafarnejad M, Lai A, Nabai L, Ghaffari A, Hojabrpour P, Kanaan N, Duronio V, Guns E, Cherkasov A, Ghahary A (2012) SPARC/SFN interaction, suppresses type I collagen in dermal fibroblasts. J Cell Biochem 113(8):2622–2632
Chiquet-Ehrismann R (1990) What distinguishes tenascin from fibronectin? FASEB J 4(9): 2598–2604
Chiquet-Ehrismann R, Tucker, RP (2011) Tenascins and the importance of adhesion modulation. Cold Spring Harb Perspect Biol 3(5):pii: a004960
Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T (1986) Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47(1):131–139
Chlenski A, Guerrero L, Peddinti R, Spitz J, Leonhardt P, Yang Q, Tian Y, Salwen H, Cohn S (2010) Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors. Mol Cancer 9(1):138
Clark MS, Thorne MAS, Reinhardt R, Drungowski M, Albrecht MW, Klages S, Beck A, Kube M, Lubzens E (2012) Long-term survival of hydrated resting eggs from Brachionus plicatilis. PLoS One 7(1):e29365
Damjanovski S, Malaval L, Ringuette MJ (1994) Transient expression of SPARC in the dorsal axis of early Xenopus embryos: correlation with calcium-dependent adhesion and electrical coupling. Int J Dev Biol 38(3):439–446
Degen M, Brellier F, Kain R, Ruiz C, Terracciano L, Orend G, Chiquet-Ehrismann R (2007) Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior. Cancer Res 67(19):9169–9179
Derr LB, Chiquet-Ehrismann R, Gandour-Edwards R, Spence J, Tucker RP (1997) The expression of tenascin-C with the AD1 variable repeat in embryonic tissues, cell lines and tumors in various vertebrate species. Differentiation 62(2):71–82
Desmoulière A, Guyot C, Gabbiani G (2004) The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 48:509–517
Doolittle RF (1984) Fibrinogen and fibrin. Annu Rev Biochem 53(1):195–229
Dorries U, Schachner M (1994) Tenascin mRNA isoforms in the developing mouse brain. J Neurosci Res 37(3):336–347
Erickson H, Inglesias JL (1984) A six-armed oligomer isolated from cell surface fibronectin preparations. Nature 311(5983):267–269
Fischer D, Chiquet-Ehrismann R, Bernasconi C, Chiquet M (1995) A single heparin binding region within the fibrinogen-like domain is functional in chick tenascin-C. J Biol Chem 270(7): 3378–3384
Fischer D, Tucker RP, Chiquet-Ehrismann R, Adams JC (1997) Cell-adhesive responses to tenascin-C splice variants involve formation of fascin microspikes. Mol Biol Cell 8(10): 2055–2075
Fitzgerald MC, Schwarzbauer JE (1998) Importance of the basement membrane protein SPARC for viability and fertility in Caenorhabditis elegans. Curr Biol 8(23):1285–1288
Ford R, Wang G, Jannati P, Adler D, Racanelli P, Higgins PJ, Staiano-Coico L (1993) Modulation of SPARC expression during butyrate-induced terminal differentiation of cultured human keratinocytes: regulation via a TGF-β-dependent pathway. Exp Cell Res 206(2):261–275
Francki A, Sage EH (2001) SPARC and the kidney glomerulus: matricellular proteins exhibit diverse functions under normal and pathological conditions. Trends Cardiovasc Med 11(1): 32–37
Francki A, McClure TD, Brekken RA, Motamed K, Murri C, Wang T, Sage EH (2004) SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells. J Cell Biochem 91(5):915–925
Frizell E, Shu-Ling L, Abraham A, Ozaki I, Eghbali M, Sage EH, Zern MA (1995) Expression of SPARC in normal and fibrotic livers. Hepatology 21(3):847–854
Fujita T, Shiba H, Sakata M, Uchida Y, Ogawa T, Kurihara H (2002) Effects of transforming growth factor-beta 1 and fibronectin on SPARC expression in cultures of human periodontal ligament cells. Cell Biol Int 26(12):1065–1072
Funk SE, Sage EH (1991) The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci U S A 88(7):2648–2652
Garrett Q, Khaw PT, Blalock TD, Schultz GS, Grotendorst GR, Daniels JT (2004) Involvement of CTGF in TGF-β1—stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Invest Ophthalmol Vis Sci 45(4):1109–1116
Gilles C, Bassuk JA, Pulyaeva H, Sage EH, Foidart J-M, Thompson EW (1998) SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines. Cancer Res 58(23):5529–5536
Giudici C, Raynal N, Wiedemann H, Cabral WA, Marini JC, Timpl R, Bächinger HP, Farndale RW, Sasaki T, Tenni R (2008) Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens. J Biol Chem 283(28):19551–19560
Goldblum SE, Ding X, Funk SE, Sage EH (1994) SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc Natl Acad Sci U S A 91(8): 3448–3452
Golledge J, Clancy P, Maguire J, Lincz L, Koblar S (2011) The role of tenascin C in cardiovascular disease. Cardiovasc Res 92(1):19–28
Gonzales TS, Coleman GC (1999) Periodontal manifestations of collagen vascular disorders. Periodontol 2000 21(1):94–105
Gooden MD, Vernon RB, Bassuk JA, Sage EH (1999) Cell cycle-dependent nuclear location of the matricellular protein SPARC: association with the nuclear matrix. J Cell Biochem 74(2): 152–167
Gulcher JR, Nies DE, Marton LS, Stefansson K (1989) An alternatively spliced region of the human hexabrachion contains a repeat of potential N-glycosylation sites. Proc Natl Acad Sci U S A 86(5):1588–1592
Gulcher JR, Nies DE, Alexakos MJ, Ravikant NA, Sturgill ME, Marton LS, Stefansson K (1991) Structure of the human hexabrachion (tenascin) gene. Proc Natl Acad Sci U S A 88(21): 9438–9442
Gundersen D, Tran-Than C, Sordat B, Mourali F, Ruegg C (1997) Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering. J Immunol 158(3):1051–1060
Hargus G, Cui Y, Schmid J-S, Xu J, Glatzel M, Schachner M, Bernreuther C (2008) Tenascin-R promotes neuronal differentiation of embryonic stem cells and recruitment of host-derived neural precursor cells after excitotoxic lesion of the mouse striatum. Stem Cells 26(8): 1973–1984
Hartenstein V, Mandal L (2006) The blood/vascular system in a phylogenetic perspective. Bioessays 28(12):1203–1210
Hasselaar P, Sage EH (1992) SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 49(3):272–283
Herold-Mende C, Mueller MM, Bonsanto MM, Schmitt HP, Kunze S, Steiner H-H (2002) Clinical impact and functional aspects of tenascin-C expression during glioma progression. Int J Cancer 98(3):362–369
Huxley-Jones J, Robertson DL, Boot-Handford RP (2007) On the origins of the extracellular matrix in vertebrates. Matrix Biol 26(1):2–11
Huynh M-H, Helene Sage E, Ringuette M (1999) A calcium-binding motif in SPARC/osteonectin inhibits chordomesoderm cell migration during Xenopus laevis gastrulation: evidence of counter-adhesive activity in vivo. Dev Growth Differ 41(4):407–418
Huynh M-H, Hong H, Delovitch S, Desser S, Ringuette M (2000) Association of SPARC (osteonectin, BM-40) with extracellular and intracellular components of the ciliated surface ectoderm of Xenopus embryos. Cell Motil Cytoskeleton 47(2):154–162
Huynh M-H, Sodek K, Lee H, Ringuette M (2004) Interaction between SPARC and tubulin in Xenopus. Cell Tissue Res 317(3):313–317
Huynh M-H, Zhu S, Kollara A, Brown T, Winklbauer R, Ringuette M (2011) Knockdown of SPARC leads to decreased cell–cell adhesion and lens cataracts during post-gastrula development in Xenopus laevis. Dev Genes Evol 220(11):315–327
Hynes RO (1999) The dynamic dialogue between cells and matrices: Implications of fibronectin’s elasticity. Proc Natl Acad Sci U S A 96(6):2588–2590
Imai K, Kusakabe M, Sakakura T, Nakanishi I, Okada Y (1994) Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases. FEBS Lett 352(2):216–218
Iruela-Arispe M, Diglio C, Sage E (1991) Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro. Arterioscler Thromb Vasc Biol 11(4):805–815
Iruela-Arispe ML, Vernon RB, Wu H, Jaenisch R, Sage EH (1996) Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function. Dev Dyn 207(2):171–183
Järvinen TAH, Józsa L, Kannus P, Järvinen TLN, Hurme T, Kvist M, Pelto-Huikko M, Kalimo H, Järvinen M (2003) Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci 116(5):857–866
Joester A, Faissner A (1999) Evidence for combinatorial variability of tenascin-C isoforms and developmental regulation in the mouse central nervous system. J Biol Chem 274(24): 17144–17151
Joester A, Faissner A (2001) The structure and function of tenascins in the nervous system. Matrix Biol 20(1):13–22
Jones FS, Burgoon MP, Hoffman S, Crossin KL, Cunningham BA, Edelman GM (1988) A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Natl Acad Sci U S A 85(7):2186–2190
Jones FS, Hoffman S, Cunningham BA, Edelman GM (1989) A detailed structural model of cytotactin: protein homologies, alternative RNA splicing, and binding regions. Proc Natl Acad Sci U S A 86(6):1905–1909
Jones FS, Jones PL (2000) The tenascin family of ECM glycoproteins: Structure, function and regulation during embryonic development and tissue remodeling. Dev Dyn 218(2):235–259
Kammerer RA, Schulthess T, Landwehr R, Lustig A, Fischer D, Engel J (1998) Tenascin-C hexabrachion assembly is a sequential two-step process initiated by coiled-coil α-helices. J Biol Chem 273(17):10602–10608
Kang Y-J, Stevenson A, Yau P, Kollmar R (2008) Sparc protein is required for normal growth of zebrafish otoliths. J Assoc Res Otolaryngol 9(4):436–451
Kaufmann B, Müller S, Hanisch F-G, Hartmann U, Paulsson M, Maurer P, Zaucke F (2004) Structural variability of BM-40/SPARC/osteonectin glycosylation: implications for collagen affinity. Glycobiology 14(7):609–619
Kaur BKF, Severson EA, Matheny SL, Brat DJ, Van Meir EG (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7(2):134–153
Kawakami K, Matsumoto K-I (2011) Behavioral alterations in mice lacking the gene for tenascin-X. Biol Pharm Bull 34(4):590–593
Kawasaki KST, Weiss K (2004) Genetic basis for the evolution of vertebrate mineralized tissue. Proc Natl Acad Sci U S A 101(31):11356–11361
Koehler A, Desser S, Chang B, MacDonald J, Tepass U, Ringuette M (2009) Molecular evolution of SPARC: absence of the acidic module and expression in the endoderm of the starlet sea anemone, & Nematostella vectensis. Dev Genes Evol 219(9):509–521
Kuhn C, Mason RJ (1995) Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol 147(6):1759–1769
Kupprion C, Motamed K, Sage EH (1998) SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 273(45):29635–29640
Laky D, Parascan L (2007) Hibernating myocardium, morphological studies on intraoperatory myocardial biopsies and on chronic ischemia experimental model. Rom J Morphol Embryol 48(4):407–413
Leahy DJ, Hendrickson WA, Aukhil I, Erickson HP (1992) Structure of a fibronectin type III domain from tenascin phased by MAD analysis of the selenomethionyl protein. Science 258(5084):987–991
Leask A, Abraham DJ (2003) The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 81(6):355–363
Leask A, Abraham DJ (2004) TGF-ß signaling and the fibrotic response. FASEB J 18(7):816–827
Leask A, Holmes A, Black CM, Abraham DJ (2003) Connective tissue growth factor gene regulation. J Biol Chem 278(15):13008–13015
Leask A, Denton CP, Abraham DJ (2004) Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J Invest Dermatol 122(1): 1–6
Limeback HF, Sodek J (1979) Procollagen synthesis and processing in periodontal ligament in vivo and in vitro. Eur J Biochem 100(2):541–550
Liu A, Mosher DF, Murphy-Ullrich JE, Goldblum SE (2009) The counteradhesive proteins, thrombospondin 1 and SPARC/osteonectin, open the tyrosine phosphorylation-responsive paracellular pathway in pulmonary vascular endothelia. Microvasc Res 77(1):13–20
Lussier C, Sodek J, Beaulieu J-F (2001) Expression of SPARC/osteonectin/BM4O in the human gut: predominance in the stroma of the remodeling distal intestine. J Cell Biochem 81(3): 463–476
Macko RF, Gelber AC, Young BA, Lowitt MH, White B, Wigley FM, Goldblum SE (2002) Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation. J Rheumatol 29(12):2565–2570
Maillard C, Malaval L, Delmas PD (1992) Immunological screening of SPARC/osteonectin in nonmineralized tissues. Bone 13(3):257–264
Marr H, Basalamah MA, Edgell CJ (1997) Endothelial cell expression of testican mRNA. Endothelium 5(3):209–219
Martina E, Degen M, Rüegg C, Merlo A, Lino MM, Chiquet-Ehrismann R, Brellier F (2010a) Tenascin-W is a specific marker of glioma-associated blood vessels and stimulates angiogenesis in vitro. FASEB J 24(3):778–787
Martina E, Chiquet-Ehrismann R, Brellier F (2010b) Tenascin-W: an extracellular matrix protein associated with osteogenesis and cancer. Int J Biochem Cell Biol 42(9):1412–1415
Martinek N, Zou R, Berg M, Sodek J, Ringuette M (2002) Evolutionary conservation and association of SPARC with the basal lamina in Drosophila. Dev Genes Evol 212(3):124–133
Maschler S, Grunert S, Danielopol A, Beug H, Wirl G (2004) Enhanced tenascin-C expression and matrix deposition during Ras/TGF-[beta]-induced progression of mammary tumor cells. Oncogene 23(20):3622–3633
Masson S, Arosio B, Luvarà G, Gagliano N, Fiordaliso F, Santambrogio D, Vergani C, Latini R, Annoni G (1998) Remodelling of cardiac extracellular matrix during β-adrenergic stimulation: upregulation of SPARC in the myocardium of adult rats. J Mol Cell Cardiol 30(8):1505–1514
Matsumoto K-I, Arai M, Ishihara N, Ando A, Inoko H, Ikemura T (1992) Cluster of fibronectin type III repeats found in the human major histocompatibility complex class III region shows the highest homology with the repeats in an extracellular matrix protein, tenascin. Genomics 12(3):485–491
McCurdy S, Baicu CF, Heymans S, Bradshaw AD (2010) Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC). J Mol Cell Cardiol 48(3):544–549
Meloty-Kapella CV, Degen M, Chiquet-Ehrismann R, Tucker RP (2006) Avian tenascin-W: expression in smooth muscle and bone, and effects on calvarial cell spreading and adhesion in vitro. Dev Dyn 235(6):1532–1542
Midwood K, Hussenet T, Langlois B, Orend G (2011) Advances in tenascin-C biology. Cell Mol Life Sci 68(19):3175–3199
Mitrovic N, Schachner M (1995) Detection of tenascin-C in the nervous system of the tenascin-C mutant mouse. J Neurosci Res 42(5):710–717
Motamed K, Blake DJ, Angello JC, Allen BL, Rapraeger AC, Hauschka SD, Sage EH (2003) Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A. J Cell Biochem 90(2):408–423
Nakatani K, Seki S, Kawada N, Kitada T, Yamada T, Sakaguchi H, Kadoya H, Ikeda K, Kaneda K (2002) Expression of SPARC by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis. Virchows Arch 441(5):466–474
Nishi T, Weinstein J, Gillespie WM, Paulson JC (1991) Complete primary structure of porcine tenascin. Eur J Biochem 202(2):643–648
Novinec M, Kordiš D, Turk V, Lenarčič B (2006) Diversity and evolution of the thyroglobulin type-1 domain superfamily. Mol Biol Evol 23(4):744–755
Nozaki M, Sakurai E, Raisler BJ, Baffi JZ, Witta J, Ogura Y, Brekken RA, Sage EH, Ambati BK, Ambati J (2006) Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest 116(2):422–429
Parks WC (1999) Matrix metalloproteinases in repair. Wound Repair Regen 7(6):423–432
Patthy L (1990) Homology of a domain of the growth hormone/prolactin receptor family with type III modules of fibronectin. Cell 61(1):13–14
Pazin DE, Albrecht KH (2009) Developmental expression of Smoc1 and Smoc2 suggests potential roles in fetal gonad and reproductive tract differentiation. Dev Dyn 238(11):2877–2890
Pearson C, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R (1988) Tenascin: cDNA cloning and induction by TGF-beta. EMBO J 7(10):2977–2982
Peterson MC (2005) Circulating transforming growth factor beta-1: a partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis. Med Sci Monit 11(7):RA229–RA232
Pichler RH, Hugo C, Shankland SJ, Reed MJ, Bassuk JA, Andoh TF, Lombardi DM, Schwartz SM, Bennett WM, Alpers CE, Sage EH, Johnson RJ, Couser WG (1996) SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int 50(6):1978–1989
Puolakkainen PA, Bradshaw AD, Brekken RA, Reed MJ, Kyriakides T, Funk SE, Gooden MD, Vernon RB, Wight TN, Bornstein P, Sage EH (2005) SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges. J Histochem Cytochem 53(5):571–581
Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH (1992) The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A 89(4):1281–1285
Rathjen FG, Wolff JM, Chiquet-Ehrismann R (1991) Restrictin: a chick neural extracellular matrix protein involved in cell attachment co-purifies with the cell recognition molecule F11. Development 113(1):151–164
Reed MJ, Vernon RB, Abrass IB, Sage EH (1994) TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J Cell Physiol 158(1):169–179
Rivera LB, Brekken RA (2011) SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity. J Cell Biol 193(7):1305–1319
Rocnik EF, Liu P, Sato K, Walsh K, Vaziri C (2006) The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. J Biol Chem 281(32):22855–22864
Sadlier DM, Connolly SB, Kieran NE, Roxburgh S, Brazil DP, Kairaitis L, Wang Y, Harris DCH, Doran P, Brady HR (2004) Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathy. J Biol Chem 279(28): 29670–29680
Sage E, Bassuk JA, Yost JC, Folkman MJ, Lane TF (1995) Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca2+-binding EF-hand sequence. J Cell Biochem 57(1):127–140
Sage EH, Reed M, Funk SE, Truong T, Steadele M, Puolakkainen P, Maurice DH, Bassuk JA (2003) Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J Biol Chem 278(39):37849–37857
Salo T, Mäkelä M, Kylmäniemi M, Autio-Harmainen H, Larjava H (1994) Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 70(2):176–182
Salonen J, Domenicucci C, Goldberg HA, Sodek J (1990) Immunohistochemical localization of SPARC (osteonectin) and denatured collagen and their relationship to remodelling in rat dental tissues. Arch Oral Biol 35(5):337–346
Sangaletti S, Stoppacciaro A, Guiducci C, Torrisi MR, Colombo MP (2003) Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma. J Exp Med 198(10):1475–1485
Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, van Vlijmen IM, van Haren B, Miller WL, Bristow J (2001) A recessive form of the Ehlers–Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 345(16):1167–1175
Schellings MW, Vanhoutte D, Swinnen M, Cleutjens JP, Debets J, van Leeuwen RE, d’Hooge J, Van de Werf F, Carmeliet P, Pinto YM, Sage EH, Heymans S (2009) Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction. J Exp Med 206(1):113–123
Schenk S, Chiquet-Ehrismann R (1994) Teanscins. In: Methods in Enzymology, Vol 245. New York Academic Press p 52–61
Schenk S, Chiquet-Ehrismann R, Battegay EJ (1999) The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation. Mol Biol Cell 10(9): 2933–2943
Scherberich A, Tucker RP, Samandari E, Brown-Luedi M, Martin D, Chiquet-Ehrismann R (2004) Murine tenascin-W: a novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development. J Cell Sci 117(4):571–581
Schiemann BJ, Neil JR, Schiemann WP (2003) SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-β-signaling system. Mol Biol Cell 14(10):3977–3988
Schnepp A, Lindgren PK, Hülsmann H, Kröger S, Paulsson M, Hartmann U (2005) Mouse testican-2. J Biol Chem 280(12):11274–11280
Shankavaram UT, DeWitt DL, Funk SE, Sage EH, Wahl LM (1997) Regulation of human monocyte matrix metalloproteinases by SPARC. J Cell Physiol 173(3):327–334
Siri A, Knäuper V, Veirana N, Caocci F, Murphy G, Zardi L (1995) Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 270(15):8650–8654
Sodek J, Zhu B, Huynh MH, Brown TJ, Ringuette M (2002) Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC. Connect Tissue Res 43(2–3):308–319
Spring J, Beck K, Chiquet-Ehrismann R (1989) Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell 59(2):325–334
Sriramarao P, Bourdon MA (1993) A novel tenascin type III repeat is part of a complex of tenascin mRNA alternative splices. Nucleic Acids Res 21(1):163–168
Strandjord TP, Madtes DK, Weiss DJ, Sage EH (1999) Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 277(3):L628–L635
Strup-Perrot C, Mathé D, Linard C, Violot D, Milliat F, François A, Bourhis J, Vozenin-Brotons M-C (2004) Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis. Am J Physiol Gastrointest Liver Physiol 287(4):G875–G885
Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K (2002) Differential regulation of TGF-β signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35(1):49–61
Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE (2003) Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 14(4):968–980
Tucker RP, Chiquet-Ehrismann R (2009) Evidence for the evolution of tenascin and fibronectin early in the chordate lineage. Int J Biochem Cell Biol 41(2):424–434
Tucker R, Drabikowski K, Hess J, Ferralli J, Chiquet-Ehrismann R, Adams J (2006) Phylogenetic analysis of the tenascin gene family: evidence of origin early in the chordate lineage. BMC Evol Biol 6(1):60
Tufty RM, Kretsinger RH (1975) Troponin and parvalbumin calcium binding regions predicted in myosin light chain and T4 lysozyme. Science 187(4172):167–169
Tung PS, Domenicucci C, Wasi S, Sodek J (1985) Specific immunohistochemical localization of osteonectin and collagen types I and III in fetal and adult porcine dental tissues. J Histochem Cytochem 33(6):531–540
Unemori E, Amento EP (1991) Connective tissue metabolism including cytokines in scleroderma. Curr Opin Rheumatol 3(6):953–959
Van Obberghen-Schilling E, Tucker RP, Saupe F, Gasser I, Cseh B, Orend G (2011) Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. Int J Dev Biol 55:511–525
Wang X, Chen W, Huang Y, Sun J, Men J, Liu H, Luo F, Guo L, Lv X, Deng C, Zhou C, Fan Y, Li X, Huang L, Hu Y, Liang C, Hu X, Xu J, Yu X (2011) The draft genome of the carcinogenic human liver fluke Clonorchis sinensis. Genome Biol 12(10):R107
Wasi S, Otsuka K, Yao KL, Tung PS, Aubin JE, Sodek J, Termine JD (1984) An osteonectinlike protein in porcine periodontal ligament and its synthesis by periodontal ligament fibroblasts. Can J Biochem Cell Biol 62(6):470–478
Weber P, Montag D, Schachner M, Bernhardt RR (1998) Zebrafish tenascin-W, a new member of the tenascin family. J Neurobiol 35(1):1–16
Weller A, Beck S, Ekblom P (1991) Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis. J Cell Biol 112(2):355–362
Willems IE, Arends J, Daemen M (1996) Tenascin and fibronectin expression in healing human myocardial scars. J Pathol 179(3):321–325
Wrana JL, Maeno M, Hawrylyshyn B, Yao KL, Domenicucci C, Sodek J (1988) Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations. J Cell Biol 106(3):915–924
Wrana JL, Overall CM, Sodek J (1991a) Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor β. Eur J Biochem 197(2):519–528
Wrana JLKT, Zhang Q, Overall CM, Aubin JE, Butler WT, Sodek J (1991b) Regulation of transformation-sensitive secreted phosphoprotein (SPPI/osteopontin) expression by transforming growth factor-beta. Comparisons with expression of SPARC (secreted acidic cysteine-rich protein). Biochem J 1(273):523–531
Xueyong L, Shaozong C, Wangzhou L, Yuejun L, Xiaoxing L, Jing L, Yanli W, Jinqing L (2008) Differentiation of the pericyte in wound healing: the precursor, the process, and the role of the vascular endothelial cell. Wound Repair Regen 16(3):346–355
Yamada KM, Yamada SS, Pastan I (1975) The major cell surface glycoprotein of chick embryo fibroblasts is an agglutinin. Proc Natl Acad Sci U S A 72(8):3158–3162
Yan Q, Weaver M, Perdue N, Sage EH (2005) Matricellular protein SPARC is translocated to the nuclei of immortalized murine lens epithelial cells. J Cell Physiol 203(1):286–294
Yoshimura H, Michishita M, Ohkusu-Tsukada K, Takahasi K (2011) Appearance and distribution of stromal myofibroblasts and tenascin-C in feline mammary tumors. Histol Histopathol 26(3): 297–305
Youssef W, Tavill AS (2002) Connective tissue diseases and the liver. J Clin Gastroenterol 35(4): 345–349
Yunker CK, Golembieski W, Lemke N, Schultz CR, Cazacu S, Brodie C, Rempel SA (2008) SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion. Int J Cancer 122(12):2735–2743
Zhao Y, Young SL (1995) TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung. Am J Physiol Lung Cell Mol Physiol 268(2):L173–L180
Zhao Y, Young SL, McIntosh JC (1998) Induction of tenascin in rat lungs undergoing bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 274(6):L1049–L1057
Zhou Y (2009) The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 460(7253):345–351
Zhou X, Tan FK, Reveille JD, Wallis D, Milewicz DM, Ahn C, Wang A, Arnett FC (2002) Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. Arthritis Rheum 46(11):2990–2999
Zhou X, Tan FK, Guo X, Wallis D, Milewicz DM, Xue S, Arnett FC (2005) Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor β1 in cultured normal human fibroblasts. Arthritis Rheum 52(1):257–261
Zhou X, Tan FK, Guo X, Arnett FC (2006) Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma. Arthritis Rheum 54(8):2626–2631
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Baratta, C.A., Brown, T.J., Al-Dhalaan, F., Ringuette, M.J. (2013). Evolution and Function of SPARC and Tenascins: Matricellular Counter-Adhesive Glycoproteins with Pleiotropic Effects on Angiogenesis and Tissue Fibrosis. In: Keeley, F., Mecham, R. (eds) Evolution of Extracellular Matrix. Biology of Extracellular Matrix. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36002-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-36002-2_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36001-5
Online ISBN: 978-3-642-36002-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)